UnitedHealth Group Incorporated $UNH Shares Sold by Vermillion Wealth Management Inc.

Key Points

• Vermillion Wealth Management Inc. significantly reduced its holdings in UnitedHealth Group by 98.3%, now holding only 174 shares worth $54,000 after selling nearly 10,000 shares during Q2.
• Equities analysts have mixed sentiments on UnitedHealth Group, with price targets ranging from $290 to $418, and an overall average target price of $358.95.
• UnitedHealth Group recently announced a quarterly dividend of $2.21 per share, leading to an annual dividend yield of 2.6%.

Vermillion Wealth Management Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 98.3% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 174 shares of the healthcare conglomerate's stock after selling 9,989 shares during the period. Vermillion Wealth Management Inc.'s holdings in UnitedHealth Group were worth $54,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. Bayforest Capital Ltd boosted its stake in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd grew its holdings in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the period. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group during the first quarter worth about $42,000. Kentucky Trust Co grew its stake in shares of UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate's stock valued at $45,000 after buying an additional 50 shares during the period. Finally, O Brien Wealth Partners LLC raised its position in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a report on Monday, August 18th. JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday, August 6th. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Oppenheimer cut their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Finally, Barclays lifted their price objective on UnitedHealth Group from $337.00 to $352.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $344.15 on Monday. The business has a 50-day simple moving average of $301.20 and a 200-day simple moving average of $358.73. The company has a market cap of $311.69 billion, a PE ratio of 14.91, a P/E/G ratio of 2.24 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% on a year-over-year basis. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.